序号 |
标题 |
次数 |
作者 |
发布时间 |
66331 |
cas:39036-04-9 1,2-二庚酰-Sn-甘油-3-磷酰胆碱(DHPC) |
187 |
zyl |
2025-01-02 |
66332 |
cas:67232-81-9 (消旋)-1,2-二棕榈酰甘油-3-磷脂酰甘油 |
86 |
zyl |
2025-01-02 |
66333 |
SOPA-Na,cas:384833-24-3,1-硬脂酰-2-油酰-sn-甘油-3-磷酸单钠盐 |
75 |
axc |
2025-01-02 |
66334 |
cas:1188-85-8 1,2-双十八烷基-sn-甘油-3-磷脂酰胆碱(18:0 Diether PC) |
86 |
zyl |
2025-01-02 |
66335 |
1-Palmitoyl-2-linoleoyl PE,cas:26662-95-3,PLinPE,1-棕榈酰-2-亚油酰-sn-甘油-3-磷脂酰乙醇胺 |
98 |
axc |
2025-01-02 |
66336 |
cas:322647-59-6 1-棕榈酰-2-亚油酰-sn-甘油-3-磷酸单钠盐(PLinPA-Na) |
76 |
zyl |
2025-01-02 |
66337 |
cas:40290-32-2 (消旋)-1,2-二棕榈酰-甘油醇 |
90 |
zyl |
2025-01-02 |
66338 |
cas:10567-21-2,(S)-1,2-二硬脂酰-sn-甘油醇,1,2-DISTEAROYL-SN-GLYCEROL |
104 |
axc |
2025-01-02 |
66339 |
cas:109786-74-5 (R)-3-(4-甲氧基苄氧基)-1,2-丙二醇 |
63 |
zyl |
2025-01-02 |
66340 |
cas:134979-01-4,2-(2-(2-氨基乙氧基)乙氧基)乙酸盐酸盐(AEEA盐酸盐),H-AEEA-OH.HCl,2-(2-(2-Aminoethoxy)ethoxy)acetic acid hydrochloride |
126 |
axc |
2025-01-02 |
66341 |
mPEG-EO,甲氧基PEG环氧乙烷 |
97 |
axc |
2025-01-02 |
66342 |
DSG-PEG 5000,cas:308805-39-2,1,2-二硬脂酰-rac-甘油-3-甲氧基聚乙二醇5000 |
89 |
axc |
2025-01-02 |
66343 |
DOctPA(Na),cas:321883-54-9,1,2- 双辛酰-sn-甘油-3-磷酸单钠盐 |
131 |
axc |
2025-01-02 |
66344 |
顺反DOTMA-Cl,cas:104872-42-6,(顺反)-1,2-二油烷氧基-3-(三甲铵基)丙烷氯盐 |
128 |
axc |
2025-01-02 |
66345 |
(S)-DPPE,cas:71357-99-8,(S)-二棕榈酰磷脂酰乙醇胺(手性异构体) |
82 |
axc |
2025-01-02 |
66346 |
SLinPS,cas:322647-11-0,1-硬脂酰-2-亚油酰磷脂酰丝氨酸(钠盐) |
77 |
axc |
2025-01-02 |
66347 |
cas:1353897-91-2,1-棕榈酰基-2-炔丙基乙酰磷脂酰胆碱,1-palmitoyl-2-(propargylacetyl)-sn-glycero-3-phosphocholine |
85 |
axc |
2025-01-02 |
66348 |
DPhPC,cas:207131-40-6,二植酰磷脂酰胆碱 |
82 |
axc |
2025-01-02 |
66349 |
DSPE-MPEG2000,cas:147867-65-0,二硬脂酰磷脂酰乙醇胺-聚乙二醇2000 |
143 |
axc |
2025-01-02 |
66350 |
DPPE,cas:923-61-5,磷脂酰乙醇胺,1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine |
158 |
axc |
2025-01-02 |
66351 |
P-LysoPC,cas:17364-16-8,1-十六酰-sn-丙三醇-磷酸胆碱 |
113 |
axc |
2025-01-02 |
66352 |
DLPC,cas:18194-25-7,1,2-二月桂酰基-sn-glycero-3-胆碱磷酸 |
78 |
axc |
2025-01-02 |
66353 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes,HSPC/Chol/DSPE-mPEG2000/MPL脂质体 |
89 |
axc |
2024-12-31 |
66354 |
DOTAP/DOPE (50/50, mol/mol) Liposomes,DOTAP/DOPE (50/50,摩尔/摩尔)脂质体 |
106 |
axc |
2024-12-31 |
66355 |
Adavosertib Liposomes, Formulation WD4,阿达沃塞替布脂质体,制剂WD4 |
267 |
axc |
2024-12-31 |
66356 |
Mirdametinib (PD0325901) Liposomes, Formulation U6-2,Mirdametinib (PD0325901)脂质体,配方U6-2 |
154 |
axc |
2024-12-31 |
66357 |
DT-061 (SMAP) Liposomes, Formulation TT-40,DT-061 (SMAP)脂质体,制剂TT-40 |
101 |
axc |
2024-12-31 |
66358 |
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1,坦那霉素(17-AAG)脂质体,配方XT28.1 |
101 |
axc |
2024-12-31 |
66359 |
Nexturastat A Liposomes,Nexturastat A脂质体,靶向脂质体定制服务 |
97 |
axc |
2024-12-31 |
66360 |
A939572 Liposomes,A939572脂质体,靶向脂质体定制服务 |
122 |
axc |
2024-12-31 |
66361 |
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2,Eganelisib (IPI-549)脂质体,制剂WNX5.2 |
161 |
axc |
2024-12-31 |
66362 |
Lificiguat (YC-1) Liposomes, Formulation FNT8P.2,Lificiguat (YC-1)脂质体,制剂FNT8P.2 |
85 |
axc |
2024-12-31 |
66363 |
SP600125 Liposomes, Formulation HZ12,SP600125脂质体,配方HZ12 |
99 |
axc |
2024-12-31 |
66364 |
Rocaglamide Liposomes, Formulation KHE9A,罗卡酰胺脂质体,配方KHE9A |
98 |
axc |
2024-12-31 |
66365 |
Gilteritinib (ASP2215) Liposomes,吉尔替尼(ASP2215)脂质体 |
90 |
axc |
2024-12-31 |
66366 |
CAS:125503-35-7 双(2,5-二氧吡咯烷-1-基)2,2'-(丙烷-2,2-二基双(磺胺基)二乙酸酯) |
115 |
zhn |
2024-12-31 |
66367 |
AZD1208 Liposomes, Formulation RB4T4,AZD1208脂质体,配方RB4T4 |
68 |
axc |
2024-12-31 |
66368 |
DiR Labeled Tumor-Accumulating Liposomes邃,DiR标记的肿瘤积聚脂质体 |
94 |
axc |
2024-12-31 |
66369 |
氧化锌量子点(ZnO QDs) 无机半导体材料 |
182 |
zhn |
2024-12-31 |
66370 |
聚多巴胺微球 |
173 |
zhn |
2024-12-31 |
66371 |
PS-R-PMMA 聚苯乙烯(PS)和聚甲基丙烯酸甲酯(PMMA)共聚物 |
294 |
zhn |
2024-12-31 |
66372 |
AgBiS₂量子点 银铋硫化物量子点 |
120 |
zhn |
2024-12-31 |
66373 |
单层石墨相氮化碳纳米片(Graphitic Carbon Nitride, g-C₃N₄) |
241 |
zhn |
2024-12-31 |
66374 |
HSPC/胆固醇/DSPE-mPEG2000 (56.2/38.5/5.3,摩尔/摩尔)脂质体(DiD标记),脂质体定制服务 |
121 |
axc |
2024-12-31 |
66375 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes (DiD-labeled),脂质体定制服务 |
127 |
axc |
2024-12-31 |